Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 6811 AL 6825

Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

Merola A, Rizzi L, Zibetti M, Artusi CA, Montanaro E, Angrisano S, Lanotte M, Rizzone MG, Lopiano L.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):552-9. doi: 10.1136/jnnp-2013-305271. Epub 2013 Jul 11.

[Advanced Parkinson's disease: clinical characteristics and treatment (part 1)]

Kulisevsky J, Luquin MR, Arbelo JM, Burguera JA, Carrillo F, Castro A, Chacón J, García-Ruiz PJ, Lezcano E, Mir P, Martinez-Castrillo JC, Martínez-Torres I, Puente V, Sesar A, Valldeoriola-Serra F, Yañez R.

Neurologia. 2013 Oct;28(8):503-21. doi: 10.1016/j.nrl.2013.05.001. Epub 2013 Jul 13.

Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease

Dodel R, Jönsson B, Reese JP, Winter Y, Martinez-Martin P, Holloway R, Sampaio C, Růžička E, Hawthorne G, Oertel W, Poewe W, Stebbins G, Rascol O, Goetz CG, Schrag A.

Mov Disord. 2014 Feb;29(2):169-76. doi: 10.1002/mds.25571. Epub 2013 Jul 16.

Mild cognitive impairment in Parkinson's disease

Yarnall AJ, Rochester L, Burn DJ.

Age Ageing. 2013 Sep;42(5):567-76. doi: 10.1093/ageing/aft085. Epub 2013 Jul 17.

Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study

Takanashi M, Shimo Y, Hatano T, Oyama G, Hattori N.

Drug Res (Stuttg). 2013 Dec;63(12):639-43. doi: 10.1055/s-0033-1351257. Epub 2013 Jul 24.

The contribution of optic flow to freezing of gait in left- and right-PD: different mechanisms for a common phenomenon?

Ehgoetz Martens KA, Pieruccini-Faria F, Silveira CR, Almeida QJ.

Parkinsonism Relat Disord. 2013 Nov;19(11):1046-8. doi: 10.1016/j.parkreldis.2013.06.011. Epub 2013 Jul 25.

Deep brain stimulation for the treatment of addiction: basic and clinical studies and potential mechanisms of action

Pierce RC, Vassoler FM.

Psychopharmacology (Berl). 2013 Oct;229(3):487-91. doi: 10.1007/s00213-013-3214-6. Epub 2013 Aug 2.

Found in transcription: accurate Parkinson's disease classification in peripheral blood

Karlsson MK, Sharma P, Aasly J, Toft M, Skogar O, Sæbø S, Lönneborg A.

J Parkinsons Dis. 2013;3(1):19-29. doi: 10.3233/JPD-120159.

Benign paroxysmal positional vertigo in Parkinson's disease

van Wensen E, van Leeuwen RB, van der Zaag-Loonen HJ, Masius-Olthof S, Bloem BR.

Parkinsonism Relat Disord. 2013 Dec;19(12):1110-2. doi: 10.1016/j.parkreldis.2013.07.024. Epub 2013 Aug 13.

Diabetic uremic syndrome studied with cerebral MR spectroscopy and CT perfusion

Acar NP, Arsava EM, Gocmen R, Dericioglu N, Topcuoglu MA.

Metab Brain Dis. 2013 Dec;28(4):711-5. doi: 10.1007/s11011-013-9427-x.

[Cellular pathology of neurodegenerative disorders]

Wakabayashi K.

Rinsho Shinkeigaku. 2013;53(8):609-17. doi: 10.5692/clinicalneurol.53.609.

Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog

Isella V, Mapelli C, Morielli N, Siri C, De Gaspari D, Pezzoli G, Antonini A, Poletti M, Bonuccelli U, Picchi L, Napolitano A, Vista M, Appollonio IM.

Parkinsonism Relat Disord. 2013 Dec;19(12):1160-3. doi: 10.1016/j.parkreldis.2013.08.008. Epub 2013 Aug 22.

Effect of partial weight-supported treadmill gait training on balance in patients with Parkinson disease

Ganesan M, Sathyaprabha TN, Gupta A, Pal PK.

PM R. 2014 Jan;6(1):22-33. doi: 10.1016/j.pmrj.2013.08.604. Epub 2013 Sep 8.

Low doses of rotigotine in patients with antipsychotic-induced parkinsonism

Di Fabio R, De Filippis S, Cafariello C, Penna L, Marianetti M, Serrao M, Pierelli F.

Clin Neuropharmacol. 2013 Sep-Oct;36(5):162-5. doi: 10.1097/WNF.0b013e3182a2ce3f.

Biomarkers, mechanisms, and potential prevention of catecholamine neuron loss in Parkinson disease

Goldstein DS.

Adv Pharmacol. 2013;68:235-72. doi: 10.1016/B978-0-12-411512-5.00012-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias